The number of movies produced in Q1 2021 hits 416 compared to 903 in Q4 2020. This indicates a decline of -53.93% quarter on quarter.
Similarly, the number of movies produced in Q1 2020 stood at 407, indicating a growth of 2.21% year-on-year.
Photo by Kevin Schmid
According to the bureau, Lagos has the highest number of movies produced by location in Q1 2021 with 149 closely followed by Onitsha with 140 movies while Benin and Bauchi recorded the least with 2 movies each respectively.
It added that data was provided by the National Film and Video Censors Board (NFVCB) and verified and validated by the NBS.
It was a celebration with excitement and glamour on Saturday, May 1 2021 when the first set of marketing professionals graduating from ExperientialNG Academy had their certificate presentation ceremony in Ikeja, Lagos.
Ezinne Okalanwa of Max Connection and Ifunaya Olisaemeka of Brainbox marketing were the first to collect their certificates after emerging as the best graduating students in Events and Experiential marketing. The duo bagged distinction at an experiential master class in marketing and was copiously congratulated by the presenter and Course Director of ExperientialNG Marketing Academy, M, Mr. Tunji Adeyinka – GMD, Republic Group.
Speaking on her experience during the course of the master class, Ezinne Okalanwa of Max Connection, an experiential marketing outfit in Lagos State Nigeria said, ” it was very interesting and mind-blowing, and every session of the class was quite revealing. I also learnt a new approach to handling marketing projects”.
While commenting on what gave her the edge and helped her to graduate with a distinction she said; “first of all, I will say it was the commitment because any task I lay my hands on, I always ensure I put in my best. Secondly, my agency which is Max Connection has been in tandem with all that we learnt here, I think that also was an added advantage in my performance.”
Speaking on the relevance of training in the marketing communications landscape, she pointed out that; “training in the marketing communications industry is very important, and that is not debatable at all, because the way I came into this training is not the same way I am returning in the area of knowledge acquisition.”
Advising young people, Ezinne disclosed that “for every level, you find yourself in the marketing strata, it’s very important you inculcate the habit of learning, and whatever level you have gotten to, always know that there is room for learning and growth. That should be a motivating factor for you to always learn, and look for a mentor in the industry to put you through. This master program is also a program that I will recommend for everybody in the experiential marketing world.”
ExperientialNG Holds Free Training For Marketers, Graduates-Brand Spur Nigeria
Speaking about her feelings at ExperientialNG academy, she stated that; “I will start with the communication platform, I think we had an excellent communication platform, it was clear, concise and very precise. The faculty did well to distil all the modules.”
“Also, special thanks to Dr Rotimi Olaniyan, the convener of this initiative, who did a lot of brilliant work from start to finish. I remember we used to have a review session on Sunday evenings to make sure everyone understands what we have been taught so far, highlighting your challenges on areas where you have issues so that it can be explained for us all to be on the same page.” She added.
Also sharing her experience, Ifunaya Olisaemeka who works with Brainbox marketing, an experiential marketing outfit in Lagos State, Nigeria said, “it was quite interesting because at the time when the training was on, I had a project which I was handling, and it was really an eye-opener for me because I was able to learn new skills.
Speaking on what made it possible for her to come out with distinction, she noted that “I will like to say that, my experience with brainbox marketing really helped, so also the level of clients I have worked with helped me as well as projects that we did at the end of the class.”
Commenting on the relevance of training as far as the marketing communications industry is concerned, she pointed out that, “training in general regardless of your discipline is very important because it will expose you to new techniques of doing things.”
“Particularly in marketing communications, it’s very important because every and again you are dealing with people and is there will be the need for you to understand their behavioural change as they evolve.”
While advising new entrant, and even those that are already in the industry as far as training is concerned, she stated that, “we all need to keep learning because as the days go by people are creating new things, so you need to learn, unlearn and relearn about new development in the industry.
“Times and things are changing, who would have known that something like COVID-19 will emerge and have such adverse effects on the marketing industry. So, it’s important to learn how to prepare yourself for the unknown in the industry.”
“my experience at ExperientialNG academy was quite interesting, we had amazing faculty with the depth of knowledge like never before, and learning under such people was a thing of joy to me.” She added
Other graduating students that were presented certificates include, Atanlusi Kehinde, Caroline Mahmoud-Lawal, Emmanuel Joshua, Ernest Igbokwe, Ighodalo Godsend, Kehinde Oloke, Otene Ene Peace among others.
Before the presentation ceremony, the free Strategic training sessions for top African Executives also organized by ExperientialNG took place digitally view zoom platform. The training was handled by three experts Stuart Hamilton, Head of International Trade, Scottish Chambers of Commerce, Dr Rotimi Olaniyan of Experiential NG, and Austin Ufumba, Managing Partner, Tytron Group.
The three Experts advised marketing leaders in Africa to strongly pay close attention to strategic thinking if they want to maintain the competitive edge in today’s very challenging business environment
In the end, a highly elated Rotimi Olaniyan, Publisher of ExperientialNG explained that ” the success of this program is not just from our efforts. We owe a lot to partners like Hybrid Studios, Abelinis, Emporium, Connect Marketing, Ideas House, Trybes, Max Connection, Francey Tansley, Linkpoint, Brainbox Marketing, Leverage group, and many others. Without them, the race would not have been so smooth and easy”.
Thousands of expected participants, including representatives of large corporate organizations, players in the SME segment of the Nigerian economy and other business owners are expected to learn useful tips for creating new wealth at a virtual conference to be hosted by Konga, Nigeria’s leading composite e-Commerce giant.
The event, tagged Konga SME CONNECT with the theme – Making New Money, is scheduled to hold on Thursday, May 20, 2021, at 10 am.
Africa’s leading digital entrepreneur and Chairman, Zinox Group, Leo Stan Ekeh, has been confirmed as the keynote speaker at the event. Ekeh, who is expected to speak for 20 minutes, will deliver useful and incisive business success tips to participants, including existing and prospective merchants on the Konga platform.
Also expected to participate in the conference are budding entrepreneurs and unemployed youths in search of opportunities to partner with Konga.
Ekeh will speak on the theme –‘‘Making New Money’’.
To confirm participation, interested participants are expected to register for the event via the link: bit.ly/kongasmeconnect
Speaking on the event, VP Online Mr. Kenny Oriola, Konga Group, affirmed that the Konga SME Connectis a unique opportunity for participants to learn from Ekeh, arguably Africa’s most successful digital disruptor, while also affording them a chance to appraise themselves of the many avenues of partnering with Konga and creating sustainable wealth.
‘‘It is no secret that the raging COVID-19 pandemic has altered the equation of commercial transactions not only in Nigeria but across the world, with SMEs and even large corporate organisations battling hard to keep their heads above water.
‘‘The prevailing situation requires business owners, entrepreneurs and even job seekers to remain alive to new and emerging opportunities in this challenging business space. In times of difficulties such as these, opportunities abound to create wealth and only those with the vision to sniff out these opportunities will benefit.
This is one of the many tips we will be sharing with new, existing and prospective merchants on the Konga platform, as well as business owners, the unemployed and other participants. Indeed, the Konga SME CONNECT is a must-attend event for all.
‘‘We are delighted to have Mr. Ekeh as the keynote speaker. We see him as a fitting testimony to the possibility of building the biggest business in Africa with astute vision, hard work, integrity and most importantly without taking any loans. We expect all participants to draw useful insights from the rich experiences Mr. Ekeh will share on the day,’’ he concluded.
The Konga SME CONNECT which will hold virtually is expected to become a regular feature for partners of the trusted e-commerce giant.
Healthcare consulting firm, Salient Advisory, has launched a health care report calling on donor agencies, governments, and impact investors to accelerate the impact and scale of African health-tech innovators working in supply chain.
As a result of COVID-19, innovative approaches to distributing medicines are growing. The report engaged with 61 of these health-tech innovators, including Mymedicines.com, Shelf Life, RxAll, MYDAWA, Pronov. Data can now reveal a consistent expansion in the ecosystem of tech-enabled supply chain companies within sub-Saharan Africa, primarily driven by companies in Ghana, Nigeria and Kenya.
The findings show a more than 100% increase in technology-enabled business models since 2018, as these companies work to change how healthcare products are distributed. Of the companies surveyed, 53% reported hoping to support the distribution of COVID-19 vaccines by providing trusted information, track-and-trace services, supporting last-mile delivery, and aiding in vaccine administration.
Salient Advisory Launches Healthcare Report, Call For Support-Brand Spur Nigeria
Propelled by COVID-19, businesses that pair telemedicine with product delivery are the most common offerings among new entrants. For the first time, the number of innovators that report operating in both urban and rural areas [49%] surpassed those operating exclusively in urban areas [48%], driving scale, impact and profitability.
As businesses continue to respond to COVID-19, the report calls for more to be done to support, nurture, fund and provide infrastructure access to innovators across Africa who can have a positive and impactful effect on the health care systems.
Building on these challenges, Salient’s key recommendations for global health actors therefore include:
Reshaping investment ecosystems to ensure more equitable funding and professionalized support is accessible to high-potential African founders, including female founders and innovators in francophone Africa.
Catalyzing partnerships between the innovators, and NGOs, industry and governments to enable the distribution of publicly subsidized products through locally-grown, tech-driven platforms, especially in rural areas.
Increasing access to affordable working capital and mechanisms to enable innovators to offer low-cost onward lending to their customers.
Reviewing, developing and harmonizing regulations for telemedicine providers and innovators offering digitally enabled direct-to-consumer distribution of medicines.
Speaking on the launch of the report, Remi Adeseun, FPSN, Director at Salient, commented:
“In our conversations with African innovators, it is clear the global pandemic has stimulated digital health care startups to develop innovative and commercially viable solutions that will transform health product distribution for consumers and providers alike. While technology-driven innovations continue to grow, our report has highlighted many constraints faced by innovators across the continent, including lack of access to capital and un-harmonized regulatory environments. Salient is now calling on all global health players, but in particular, those who operate across Africa, to move quickly to engage high-potential innovations, to build health care supply chains of the future”.
Cheikh Oumar Seydi, Director, Africa, at the Bill and Melinda Gates Foundation, also commented:
“The COVID-19 pandemic has impacted everyone in Africa, and in response governments, the private sector, donors, and health workers have stepped up. This new survey shows that sub-Saharan African start-ups are keen to do more to support the distribution of essential medicines and vaccines and are already investing in the technology to do so.
“As we work to deliver a fair and equitable approach, we must leverage partnerships and collaborate sector to sector, locally and internationally, to strengthen health care systems and achieve universal health coverage.”
May 17, 2021 – Today is World Hypertension Day. This year’s theme is Measure Your Blood Pressure Accurately, Control It, Live Longer, focusing on combatting low awareness rates worldwide, especially in low to middle-income areas, and accurate blood pressure measurement methods.
Often neglected as just a headache or high BP, hypertension can lead to serious health crisis if not treated properly at the right time.
Hypertension affects more than 30% of the adult population worldwide, more than one billion people around the world. It is the main risk factor for cardiovascular diseases, especially coronary heart disease and stroke, but also for chronic kidney disease, heart failure, arrhythmia and dementia.
The burden of hypertension is felt disproportionately in low- and middle-income countries, where two-thirds of cases are found, largely due to increased risk factors in those populations in recent decades.
What’s more, around half of people living with hypertension are unaware of their condition, putting them at risk of avoidable medical complications and death. Accurate blood pressure (BP) measurement is essential for the proper diagnosis and management of hypertension.
BP measurement is perhaps the most commonly performed procedure in clinical medicine and, although it seems simple at first glance, current suboptimal measurement leads to negatively impacting clinical management decisions in 20 – 45% of cases.
World Hypertension Day is a great oppourinity to do a basic check on our health status particularly amid the coronavirus pandemic and a deluge of tragic news around coming in every day.
On World Hypertension Day, here is a look at the theme and a few essential facts that can help raise awareness about the crucial health parameter that can prevent a crisis.
What is hypertension?
The term hypertension is often used casually but do we know what it actually refers to? According to the World Health Organisation (WHO), ”hypertension, also known as high or raised blood pressure, is a condition in which the blood vessels have persistently raised pressure.
Blood is carried from the heart to all parts of the body in the vessels. Each time the heartbeats, it pumps blood into the vessels. Blood pressure is created by the force of blood pushing against the walls of blood vessels (arteries) as it is pumped by the heart. The higher the pressure, the harder the heart has to pump.”
World Hypertension Day 2021: Important facts
Many people with high blood pressure often have no symptoms, ”even if blood pressure readings reach dangerously high levels.”
A few people ”may have headaches, shortness of breath or nosebleeds, but these signs and symptoms aren’t specific and usually don’t occur until high blood pressure has reached a severe or life-threatening stage.”
Blood pressure should be checked ”at least every two years starting at age 18. If you’re age 40 or older, or you’re 18 to 39 with a high risk of high blood pressure, ask your doctor for a blood pressure reading every year.”
Common risk factors include age, family history, being overweight or obese, sedentary lifestyle, smoking, using too much salt in your food, drinking too much alcohol and high levels of stress.
Shoprite Holdings has appointed respected and experienced accounting professionals and board members Nonkululeko Gobodo and Linda de Beer to its board as independent non-executive directors.
Both will also serve as members of the company’s Audit & Risk Committee.
Gobodo is a chartered accountant and pioneer in her field who established her own successful accounting and audit firm during apartheid. The firm grew to become SizweNtsalubaGobodo (SNG), the largest black accounting firm in South Africa and fifth-largest overall, which in 2018 acquired the Grant Thornton South Africa licence.
Gobodo has extensive experience as a non-executive director and is on the board of PPC, a member of the Gauteng Ethics and Anti-Corruption Commission and a joint caretaker at the Independent Regulatory Board for Auditors (IRBA). She has been on the boards of Clicks Group, Mercedes-Benz SA, Imperial, the SA Maritime Authority South African Revenue Service, IRBA and the Senior Partners Forum of the SA Institute of Chartered Accountants.
“This is a great opportunity for me to work with a group that has been going through major innovations in the last few years, doing exciting things that are changing the experience of its customers.” – Nonkululeo Gobodo
She said she was eager to work with a group that “is committed to its purpose of feeding the nations of Africa and catering for all people, including poorer communities, with affordable products such as bread below R5 and affordable sanitary pads”.
De Beer is a chartered accountant and chartered director with a master’s degree in taxation. She has extensive experience as an independent non-executive director and is on the boards of Aspen, Momentum Metropolitan Holdings and Tongaat Hulett.
She has advised on governance, accounting and reporting and was a member of the King Committee on Corporate Governance and chaired the Financial Reporting Investigations Panel of the JSE. In April 2020 she was appointed chair of the Public Interest Oversight Board, which oversees and monitors international audit and ethics standard-setting.
Commenting on why she accepted the role, de Beer said:
“I believe that good, well-governed companies form the backbone of value creation for everybody – including shareholders, employees, suppliers, customers and the community at large.”
“Well governed companies are the success stories that give confidence in our country and its markets, which is very important for foreign investment.” – Linda de Beer
She said Shopriteis the perfect example of a company that contributes to the community and touches the lives of so many South Africans (and beyond) on a daily basis. “Who wouldn’t want to be a part of that and play a role in such an iconic company,” she said. As she has not been involved in the retail sector as a director, “I believe it will be a great development opportunity for me too”.
These appointments, effective from 11 May 2021, follow the November 2020 appointment of Wendy Lucas-Bull as Shoprite’s chair.
May 17, 2021 – The Sanofi and GSK adjuvanted recombinant COVID-19 vaccine candidate achieved strong rates of neutralizing antibody responses, in line with those measured in people who have recovered from COVID-19, in all adult age groups in a Phase 2 study with 722 volunteers. A global pivotal Phase 3 study is expected to start in the coming weeks.
The Phase 2 interim results showed 95% to 100% seroconversion following a second injection in all age groups (18 to 95 years old) and across all doses, with acceptable tolerability and with no safety concerns. Overall, the vaccine candidate elicited strong neutralizing antibody levels that were comparable to those generated by natural infection, with higher levels observed in younger adults (18 to 59 years old).
Photo by benjamin lehman
After a single injection, high neutralizing antibody levels were generated in participants with evidence of prior SARS-CoV-2 infection, suggesting strong potential for development as a booster vaccine.
“Our Phase 2 dataconfirm thepotential of this vaccineto play a role in addressing this ongoing global public health crisis, as we know multiple vaccines will be needed,especially as variants continue to emerge andthe need for effective andbooster vaccines, which can be stored at normal temperatures, increases”,said Thomas Triomphe, Executive Vice President and Global Head of Sanofi Pasteur.
“With these favourable results,we are set to progress to a global Phase 3 efficacy study.Welook forward to generating additional data and workingwith our partners around the world to make ourvaccine available as quickly as possible.”
“These positive data show the potential of this protein-based adjuvanted vaccine candidate in the broader context of the pandemic, including the need to address variants and to provide for booster doses.We believe that this vaccine candidate can make a significant contribution to the ongoing fight against COVID-19 and will move to Phase 3 as soon as possible to meet our goal of making it available before the end of the year.”
Based on these positive Phase 2 interim results, the companies plan to initiate a global Phase 3, randomized, double-blind study with the 10µg dose, in combination with GSK’s pandemic adjuvant, in the coming weeks. This Phase 3 trial is expected to enrol more than 35,000 adult participants from a broad range of countries and will assess the efficacy of two vaccine formulations including the D614 (Wuhan) and B.1.351 (South African) variants.
In parallel, the companies intend to conduct booster studies with various variant formulations in order to assess the ability of a lower dose of the vaccine to generate a strong booster response regardless of the initial vaccine platform received.
Pending positive Phase 3 outcomes and regulatory reviews, the vaccine is expected to be approved in the fourth quarter of 2021.
More about the Phase 2 study
The Phase 2 study interim results show that the adjuvanted recombinant vaccine candidate triggered strong immune response amongst adults of all age groups with 95% to 100% seroconversion rates and neutralizing antibodies that were comparable to those generated by natural infection. The high titers observed in the non-naïve population after one dose of the vaccine candidate also suggest it may have strong potential for use as a booster vaccine. Full results of the Phase 2 study will be published in a peer-reviewed journal.
The randomized, double-blind, multi-centre-dose-ranging study was conducted in healthy adults aged 18 years of age and older, including those with high-risk medical conditions, to evaluate the safety, reactogenicity, and immunogenicity of two injections given 21 days apart, with 3 antigen dose levels of 5, 10 and 15 µg. Beginning in February 2021, the study enrolled 722 volunteers in the U.S. and Honduras. It included equivalent numbers of adults 18 to 59 years and those 60 years and above.
This effort is supported by federal funds from the Biomedical Advanced Research and Development Authority, part of the office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services in collaboration with the U.S. Department of Defense Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense under Contract # W15QKN-16-9-1002.
About the Sanofi / GSK partnership
In the partnership between the two companies, Sanofi provides its recombinant antigen and GSK contributes its pandemic adjuvant, both established vaccine platforms that have proven successful against influenza. The recombinant technology combined with GSK’s adjuvant is designed to offer the advantages of stability at temperatures used for routine vaccines, making it easily implementable and easier to distribute at a global scale through existing infrastructures where vaccines are stored at normal refrigerator temperature. It also offers the potential to generate high and sustained immune responses, and the potential to prevent virus transmission.
Shots on goal in the fight against the COVID-19 pandemic
In addition to the adjuvanted recombinant protein-based vaccine in collaboration with GSK, Sanofi is developing a messenger RNA vaccine in partnership with Translate Bio. In March 2021, Sanofi and Translate Bio initiated a Phase 1/2 clinical trial of their mRNA COVID-19 vaccine candidate, in order to assess safety, immune response and reactogenicity, after preclinical data showed high neutralizing antibody levels. The first results are expected in the third quarter of 2021.
Sanofi is also committed to providing manufacturing support to other vaccine producers. The company recently announced it will manufacture up to 200 million doses of Moderna’s COVID-19 vaccine for the U.S., starting in September 2021. Earlier this year, Sanofi also announced the company will provide support to BioNTech for 125 million doses for the European Union. In February, Sanofi said it would support Johnson & Johnson for the production of its COVID-19 vaccine at a rate of approximately 12 million doses per month.
In addition to developing its two COVID-19 vaccines, Sanofi is the only company to leverage its manufacturing capacity and expertise for three different COVID-19 vaccines to support the global vaccines supply and help combat the pandemic.
17 May 2021 – Geneva Long working hours led to 745 000 deaths from stroke and ischemic heart disease in 2016, a 29 per cent increase since 2000, according to the latest estimates by the World Health Organization and the International Labour Organization published in Environment International today.
In a first global analysis of the loss of life and health associated with working long hours, WHO and ILO estimate that, in 2016, 398 000 people died from stroke and 347 000 from heart disease as a result of having worked at least 55 hours a week. Between 2000 and 2016, the number of deaths from heart disease due to working long hours increased by 42%, and from stroke by 19%.
Photo by Brandy Kennedy
This work-related disease burden is particularly significant in men (72% of deaths occurred among males), people living in the Western Pacific and South-East Asia regions, and middle-aged or older workers. Most of the deaths recorded were among people dying aged 60-79 years, who had worked for 55 hours or more per week between the ages of 45 and 74 years.
With working long hours now known to be responsible for about one-third of the total estimated work-related burden of disease, it is established as the risk factor with the largest occupational disease burden. This shifts thinking towards a relatively new and more psychosocial occupational risk factor to human health.
The study concludes that working 55 or more hours per week is associated with an estimated 35% higher risk of a stroke and a 17% higher risk of dying from ischemic heart disease, compared to working 35-40 hours a week.
Further, the number of people working long hours is increasing and currently stands at 9% of the total population globally. This trend puts even more people at risk of work-related disability and early death.
The new analysis comes as the COVID-19 pandemic shines a spotlight on managing working hours; the pandemic is accelerating developments that could feed the trend towards increased working time.
“The COVID-19 pandemic has significantly changed the way many people work,“ said Dr Tedros Adhanom Ghebreyesus, WHO Director-General. “Teleworking has become the norm in many industries, often blurring the boundaries between home and work.
In addition, many businesses have been forced to scale back or shut down operations to save money, and people who are still on the payroll end up working longer hours. No job is worth the risk of stroke or heart disease. Governments, employers and workers need to work together to agree on limits to protect the health of workers.”
“Working 55 hours or more per week is a serious health hazard,” added Dr Maria Neira, Director, Department of Environment, Climate Change and Health, at the World Health Organization. “It’s time that we all, governments, employers, and employees wake up to the fact that long working hours can lead to premature death”.
Governments, employers and workers can take the following actions to protect workers’ health:
governments can introduce, implement and enforce laws, regulations and policies that ban mandatory overtime and ensure maximum limits on working time;
bipartite or collective bargaining agreements between employers and workers’ associations can arrange a working time to be more flexible, while at the same time agreeing on a maximum number of working hours;
employees could share working hours to ensure that numbers of hours worked do not climb above 55 or more per week.
Point-of-Sale (POS) Transaction Values to Exceed $17.3 Trillion Globally by 2026, as Emerging Smart Features Drive AdoptionRising over $3.7 Trillion in the Next Five Years
17th May 2021: A new study by Juniper Research has found that the total value of transactions processed by POS Transaction terminals will exceed $17.3 trillion in 2026, from $14.8 trillion in 2021; growing 28%. The growth is driven by a continually evolving payment processing landscape in which cash plays a reduced role.
The report found that POS vendors must ensure they support omnichannel retail business models and are prepared to compete with alternative payment methods such as QR code payments.
The pandemic and increased cashless currencies bring challenges that POS vendors must manage, with retail moving online and enabling contactless processing. The report recommends that POS vendors must integrate smart capabilities, including stock management and data analytics to their terminals, to maximise the value of their platforms to end users.
The following vendors were ranked as the established leaders:
Fiserv
PAX Technology
PayPal
Square
Worldline
Verifone
These vendors have achieved significant worldwide penetration and comprehensive breadth and depth of solutions in the POS market.
mPOS Terminal Growth Outstripping Dedicated POS
The research predicts that shipments of mPOS (mobile point of sale) terminals will grow from 20 million in 2021 to 32 million by 2026. This represents a growth of 56% over the next 5 years. It found that this growth will be fuelled by the accelerated transition from cash, with previously cash-only vendors adopting mPOS solutions rapidly.
The report identified that emerging markets will offer the greatest opportunities for mPOS vendors during this time, as demand for digital payments grows in these regions. The research recommends that vendors build a strong mPOS offering; backed up by free access to business insights, to capitalise on this growth potential.
Juniper Research provides research and analytical services to the global hi-tech communications sector; providing consultancy, analyst reports and industry commentary.
Shareholders of NPF Microfinance Bank Plc will receive 20 kobo for every share of the company in their portfolio on Thursday, May 27, 2021, the board has confirmed.
The payment is the dividend recommended by the board for the financial year ended December 31, 2020, a notice from the organisation disclosed.
In the disclosure from the firm, Brand Spur reported that the payment would be made to shareholders whose names appear on the register of members as at the close of business on May 6, 2021.
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
